Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/53058


Part 11 and Drug Development: A Q&A Reference Guide


Description: Part 11 requirements have now taken their place alongside longstanding regulations such as GCP and GLP as standards critical to those developing new drugs. As computer technology, the Internet, email, and other technological advances have worked their way into virtually every aspect of new drug development, so too have emerging and rapidly evolving Part 11 standards.

Although the FDA's "new" Part 11 approach unveiled in late 2003 was seen as good news by industry, it has also spawned a new generation of difficult questions for every person involved in the drug development process. From clinical research associates (CRA) and clinical site staff dealing with EDC-based systems and electronic patient diaries to clinical data managers coping with complex clinical data management systems to regulatory affairs staff making electronic submissions, Part 11 standards are very much an element of everyday life.

Developed by industry experts, The "new" Part 11 and Drug Development: A Q&A Reference Guide addresses the most common and difficult questions regarding the day-to-day interpretation and implementation of the all-new Part 11 standard today. What specific clinical records and systems must be Part 11 compliant? What are Part 11 standards for email systems used to communicate study-related data, information, and queries from sponsor/CROs to clinical trial sites? And how, specifically, is Part 11 relevant to clinical trial monitors, study sites, IRBs, data managers, trial auditors and others? From electronic signatures to electronic record retention and from clinical system validation to creating audit trails, this new reference guide provides authoritative answers to the Part 11-related questions confronting development professionals today. As the ultimate Part 11 resource guide for pharma R&D staff, The "new" Part 11 and Drug Development: A Q&A Reference Guide provides, in one pocket-sized handbook:

- Detailed commentary from leading Part 11 experts on 150+ questions across 14 areas critical to the drug development process.
- The latest insights and commentary from FDA officials on critical Part 11 issues.
- The Part 11 regulations, the FDA's August 2003 Part 11 Scope and Application Guidance, and other important guidance documents.




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/53058

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 23/11/2008 15:45:55
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Part 11 and Drug Development: A Q&A Reference Guide

Web Address:
http://www.researchandmarkets.com/reports/53058

Office Code:
OCIEHLOTMSQ

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €27.00 + EUR€ 50.00 Shipping/Handling *

* Shipping/Handling is only charged once per order.


Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 23/11/2008 15:45:55


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World